School of Medicine, University College Dublin, Dublin, Ireland.
School of Medicine, University College Dublin, Dublin, Ireland; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
Neurosci Biobehav Rev. 2023 Jul;150:105116. doi: 10.1016/j.neubiorev.2023.105116. Epub 2023 Mar 2.
Muscular dystrophies vary in presentation and severity, but are associated with profound disability in many people. Although characterised by muscle weakness and wasting, there is also a very high prevalence of sleep problems and disorders which have significant impacts on quality of life in these individuals. There are no curative therapies for muscular dystrophies, with the only options for patients being supportive therapies to aid with symptoms. Therefore, there is an urgent need for new therapeutic targets and a greater understanding of pathogenesis. Inflammation and altered immunity are factors which have prominent roles in some muscular dystrophies and emerging roles in others such as type 1 myotonic dystrophy, signifying a link to pathogenesis. Interestingly, there is also a strong link between inflammation/immunity and sleep. In this review, we will explore this link in the context of muscular dystrophies and how it may influence potential therapeutic targets and interventions.
肌肉萎缩症的表现和严重程度各不相同,但在许多人中都与严重的残疾有关。尽管以肌肉无力和萎缩为特征,但也有很高的睡眠问题和障碍的患病率,这些问题和障碍对这些人的生活质量有重大影响。肌肉萎缩症没有治愈疗法,患者唯一的选择是支持性治疗来缓解症状。因此,迫切需要新的治疗靶点和对发病机制的更深入了解。炎症和免疫改变是一些肌肉萎缩症中起重要作用的因素,在另一些肌肉萎缩症中也有新兴作用,如 1 型强直性肌营养不良症,这表明与发病机制有关。有趣的是,炎症/免疫与睡眠之间也有很强的联系。在这篇综述中,我们将探讨肌肉萎缩症发病机制中的这种联系,以及它如何影响潜在的治疗靶点和干预措施。